Company: Bone Therapeutics
Job title: CMO
Dr. Olivier Godeaux is a seasoned biopharmaceutical industry executive with a proven track record in advancing drug candidates through all phases of development to regulatory approval and commercial launch. Dr. Godeaux held various senior positions in clinical development at fast-growing biotechnology companies, clinical research organisations and global pharmaceutical companies such as Johnson & Johnson, GSK and UCB, where he led several complex, large-scale Phase III clinical studies involving 1,000+ patients in Europe, US and Japan. Olivier Godeaux received both his Doctor of Medicine and his Master in Public Health degrees from the Université Catholique de Louvain (UCLouvain), Belgium. As Chief Medical Officer, Olivier Godeaux is responsible for the development and execution of the Company’s clinical development strategy, advancing its late-stage products through clinical development towards commercialisation, while playing a crucial role in the interactions with regulatory authorities, clinical experts and key opinion leaders.
Assessing the Efficacy & Safety of Allogeneic Osteoblastic Cells (ALLOB) Single Implantation in Tibial Fracture 9:00 am
day: Day Two